Karuna, Cerevel might be just the start of psychiatry drug M&A

Karuna, Cerevel might be just the start of psychiatry drug M&A

Submitted by admin on January 23, 2024 - 11:17am
Source: 
BioPharma Dive
News Tags: 
M&A
Karuna Therapeutics
Cerevel Therapeutics
schizophrenia
AbbVie
Bristol Myers Squibb
Headline: 
Karuna, Cerevel might be just the start of psychiatry drug M&A
snippet: 

With two biotech buyouts, schizophrenia drugs appear back on pharma’s radar. Deal documents suggest others besides Bristol Myers and AbbVie may be looking.

Do Not Allow Advertisers to Use My Personal information